
Disclosure of PHI Through Marketing Activities 
HIPAA Policy:  Privacy 05 

 
 

1 
 

 

 

Summary:  Limits the scope of marketing communications to patients. 
 
Affected Individuals:  Staff at HIPAA Covered Entities 

 

1.0 PURPOSE 
 

To protect patient privacy rights regarding marketing activities and to comply with the 
Health Insurance Portability and Accountability Act (HIPAA) Privacy Regulations and 
the Health Information Technology for Economic and Clinical Health (HITECH) Act. 

 
2.0 SCOPE 

 
The UM Disclosure of Protected Health Information (PHI) through Marketing Activities 
Policy applies to any UM employee who discloses PHI for marketing activities. 

 
3.1 STANDARDS 

 
Marketing  communications  to  patients  in  the  absence  of  the  patientâ€™s  written 
authorization is prohibited. The following exceptions apply: 

 
1) UM receives no compensation for the communication; 

 
2) The communication is face-to-face; 

 
3) The communication is to provide refill reminders or other communication 
involving a drug or biologic the patient is currently being prescribed and the 
payment is limited to reasonable reimbursement of the costs of the 
communication (no profit); 
4) The communication is via newsletters, mailings or other means regarding 
treatment options, health related information, disease-management programs, 
wellness programs, or other community-based initiatives or activities in which 
UM is participating. 

 

 
 
 
 



Disclosure of PHI Through Marketing Activities 
HIPAA Policy:  Privacy 05 

 
 

2 
 

 

 

5) The communication involves general health promotion, rather than the 
promotion of a specific product or service; or 

 
6) The communication involves government or government-sponsored 
programs. 

 
4.0 CONTACT INFORMATION 

 
For questions about the UM Disclosure of PHI through Marketing Activities Policy or for 
more information, call the Office of General Counsel at 662-915-7014. 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


